Develops biologic therapies for myeloproliferative neoplasms, hepatitis and other diseases, aimed at improving patients' health and quality of life. Operates a TFDA‑certified cGMP biologics manufacturing facility in Taichung designed to meet U.S. FDA and EMA requirements.